Skip to main content
. 2021 Jul 6;35(11):6366–6373. doi: 10.1007/s00464-021-08596-7

Table 1.

Patient baseline

Patient n Gender Age at surgery (years) Weight (Kg) BMI (Kg/m2) Comorbidity Drug therapy at time of surgery Pre-operative Ultrasound Pre-operative MRI Pre-operative diagnosis anatomy variants Timing administration ICG prior to surgery (hours)
1 F 13.1 25 12.4 Drepanocytosis, epilepsy Sodium valproate, ursodeoxycholic acid (UDCA) Yes Yes No 8
2 F 7.4 26 16.9 Hereditary spherocytosis No Yes Yes No 13
3 F 15.7 45 19.2 No UDCA Yes Yes No 12
4 F 12.9 51 19.6 Drepanocytosis Amoxicillin Yes Yes No 13
5 F 6.4 32 21.9 Mirizzi’s syndrome UDCA Yes Yes No 14
6 F 12 71 27.7 No No Yes No No 21
7 F 18 87 30.1 No No Yes No No 20
8 F 13 61.2 24.5 No No Yes No No 18
9 M 18 65.5 23.2 No No Yes No No 20
10 F 13 87 34.8 No No Yes No No 18
11 M 17 88.5 31.3 Chronic hepatitis B No Yes No No 20
12 F 17 56 21.3 Crigler–Najjar syndrome type II Phenobarbital Yes No No 18
13 F 9 37.5 19.1 No No Yes No No 19